Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sativex on brain function in multiple sclerosis patients with spasticity
2005-000393-47Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in multiple sclerosis (MS) and Muscle spasm (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoints: Brain function changes by fMRI and Neurophysiologic measures. Started Mar 2007; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)Muscle spasm
Beyond the preview
Go deeper on 2005-000393-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000393-47.